Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Newsletter > Medical Device > Orthopaedics Business News
Newsletter
Advanced Material (25)
Automotive (7)
Banking (11)
Biotechnology (10)
Construction (4)
Consumer Goods (11)
Defense & Aerospace (11)
Electronic Components (11)
Energy (9)
Environment (6)
Food (22)
Industrial Machinery (2)
Medical Device (7)
Pharmaceutical (28)
Telecom & IT (77)
Newsletter

Orthopaedics Business News

Published by Espicom Business Intelligence
Published Issues / Year: 12 Product code 5864
Content info  
Price
US $ 1025 1 Year Web Access (Single User License)
US $ 1025 1year Hard Copy
US $ 1025 1year PDF by e-mail


Orthopaedics Business News published by Espicom Business Intelligence. This newsletter price starts from US $ 1025.

Introduction

Your regular briefing on the companies and products that are shaping orthopaedic markets around the world.

Orthopaedics Business is a new business information service designed specifically to keep busy executives in touch with the companies, products and market for all types of orthopaedic device equipment.

More than ever before, the orthopaedic sector is taking a central position in industry research efforts. Orthopaeics Business incorporates a wide range of primary source material, augmented with data from Epicom's unique intelligence database.

Every issue provides an easy-to-read layout with highly detailed reporting, on:

Corporate News
The latest acquisitions, mergers, divestitures, litigation, restructuring and investment news.

Agreement News
Full details of major agreements between companies and organisations in the othopaedics business field.

Financial News
Up or down? Quarterly, half-yearly and yearly financial results and performance are regularly brought into the spotlight in an easy-to-read format.

Product News
Who's doing what, and where? Orthopaeics Business reports on the latest product introductions, clearances and filings of medical devices and equipment worldwide.

R&D News
New technologies, patents, developments and clinical trials are closely monitored.

Back to Top